臨床研究等提出・公開システム

Indocyanine Green (ICG) fluorescence imaging for accurate intraoperative detection of early gastric cancer (Indocyanine Green (ICG) fluorescence imaging for accurate intraoperative detection of early gastric cancer)

Indocyanine Green fluorescence imaging for accurate intraoperative detection of early gastric cancer (Indocyanine Green fluorescence imaging for accurate intraoperative detection of early gastric cancer)

Tanaka Chie

Nagoya University Hospital

65 Tsurumai-cho, Showa-ku, Nagoya 466-8550

chtanaka@med.nagoya-u.ac.jp

Tanaka Chie

Nagoya University Hospital

65 Tsurumai-cho, Showa-ku, Nagoya 466-8550

+81-52-744-2249

chtanaka@med.nagoya-u.ac.jp

Recruiting

Feb. 01, 2016

Interventional

single arm study

open(masking not used)

uncontrolled control

single assignment

treatment purpose

1. patients who are histologically proven gastric adenocarcinoma or esophagogastric junction adenocarcinoma
2. patients who are diagnosed clinical T1 according to the 14th edition of Japanese Classification of Gastric Carcinoma
3. patients who receive informed consent

1. patients who have allergy to ICG
2. patients who have allergy to iodine
3. patients who are judged to be ineligible for subject by resercher

Both

Early gastric cancer or esophagogastric junction adenocarcinoma

Injection of ICG to the mucosal layer of stomach or esophagus

Early gastric cancer or esophagogastric junction adenocarcinoma

ICG

C06

Differences in length between preoperatively-determined and actual surgical margins

Detection rate of ICG during gastrectomy, size of visualized ICG, morbidity of preoperative upper endoscopy, prevalence of adverse effects of ICG injection, operative time, intraoperative estimated blood loss, pathological findings (e.g. tumor depth, proximal and distal margin), postoperative morbidity rate, frequency of additional resection

+81-52-744-2479

Feb. 04, 2019

none